Research Area

Metabolic & Body-Weight Research

Incretin and growth-hormone-axis compounds studied in metabolic, glycemic, and body-weight research — from the GLP-1 / GIP / glucagon agonists to GHRH analogs and mitochondrial-derived peptides. Several are investigational or approved as finished drugs in defined clinical populations; Renova supplies research-grade material only.

Retatrutide (GLP-3)

Metabolic

Phase 3 (investigational)

Studied for metabolic & body-weight research.

Read the guideView product

Tirzepatide

Metabolic

Approved formulations exist

Studied for metabolic & body-weight research.

Read the guide

Semaglutide

Metabolic

Approved formulations exist

Studied for metabolic & body-weight research.

Read the guide

Tesamorelin

Growth-hormone axis

Approved formulations exist

Studied for visceral/hepatic fat research.

Read the guideView product

MOTS-C

Mitochondrial

Preclinical / early research

Studied for metabolism & insulin-sensitivity research.

Read the guideView product

Compare within this area

Retatrutide (GLP-3) vs TirzepatideRetatrutide (GLP-3) vs SemaglutideSemaglutide vs TirzepatideMOTS-C vs Tesamorelin
← All research areasResearch libraryFull catalog

Research use only. This page groups compounds by research area for educational reference. It is not medical, therapeutic, or dosing advice. Compounds sold by Renova Wellness™ are for in-vitro laboratory research and are not for human or animal consumption.